GLP-1 and metabolic support

What the medication is doing

GLP-1 is a hormone your gut already releases in response to food. It contributes to the sense of having eaten enough, slows how quickly the stomach empties, and supports glucose regulation after meals.

GLP-1 receptor agonists work through that existing pathway. The practical effect most people report first is that food noise quiets down and portions fall without a deliberate effort to restrict.

The lean mass problem

Any substantial reduction in energy intake costs some lean mass alongside fat. That is true of dieting in general and it is true here, and it is the single most important thing to manage during a program.

Muscle is metabolically active tissue. Losing a large share of it while the scale moves produces a smaller body that handles glucose worse and is harder to maintain, which is a poor trade even when the weight number looks like progress.

• Protein intake targeted deliberately, since appetite suppression makes it easy to undereat protein specifically.
• Resistance training through the whole course, not started afterwards.
• Body composition tracked rather than body weight alone.
• Adequate hydration and attention to fiber, since slower gastric emptying changes digestion.

What gets measured

Weight alone cannot tell you whether metabolic health improved. Fasting insulin and HOMA-IR describe how hard the system is working to keep glucose in range, and they often move before glucose itself does.

These are the markers we recommend tracking if you choose to do lab work, since weight alone cannot show whether metabolic health improved. It also gives a clear basis for deciding what happens when the course ends.

• Fasting insulin and HOMA-IR.
• Fasting glucose and HbA1c.
• Lipids, including ApoB where available.
• Body composition, including lean mass.

Common side effects and the exit plan

Gastrointestinal effects are the most commonly reported, particularly nausea, and they are usually most noticeable after a dose increase. Titration schedules exist for that reason, and moving faster than the schedule is rarely a good trade.

The question of what happens when the medication stops deserves an answer before starting rather than after. Appetite regulation returns toward its previous state, so the plan needs to include what maintains the result: the eating pattern, the training, and the markers that would prompt a further conversation.

Who this is not for

These are prescription medications with real contraindications, and the decision to prescribe sits with an independent licensed provider in our partnered network, who reviews your history and any lab work you choose to have done. Personal or family history of certain conditions, current medications, and pregnancy or plans to become pregnant all change the answer.

Some intakes end with a different recommendation, most often addressing sleep, nutrition, or an untreated metabolic driver first. Nothing here is a prescription or a diagnosis.